Ryanodine receptor 1-mediated Ca2+ signaling and mitochondrial reprogramming modulate uterine serous cancer malignant phenotypes

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, August 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#41 of 2,207)
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 3 tweets from 2 users, with an upper bound of 1,391 followers.

RT @JournalofExper1: New study!💣 Ryanodine receptor 1-mediated Ca2+ signaling and mitochondrial reprogramming modulate uterine serous canc…

New study!💣 Ryanodine receptor 1-mediated Ca2+ signaling and mitochondrial reprogramming modulate uterine serous cancer malignant phenotypes For free 👁️ https://t.co/zC1eC5WUNe #UterineCancer #CalciumSignaling @IREISGufficiale https://t.co/DPKh3m6bC8

New article: Ryanodine receptor 1-mediated Ca2+ signaling and mitochondrial reprogramming modulate uterine serous cancer malignant phenotypes https://t.co/4tqf6Ceuw7 #uterinecancer #oncology https://t.co/fRZIPGR6tA

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity.